Serge H. Boyer

Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases

Scott J. Hecker, K. Raja Reddy, Maxim Totrov et al. · Journal of Medicinal Chemistry · 2015 · 388 citations · Full text

Klebsiella Pneumoniae, Pharmacotherapy, Antimicrobial Chemotherapy +22

Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index

Mark D. Erion, Edward E. Cable, Bruce R. Ito et al. · Proceedings of the National Academy of Sciences · 2007 · 262 citations · Full text

Pharmacotherapy, Fatty Liver Disease, Metabolic Syndrome +18

Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases

Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya et al. · Journal of Medicinal Chemistry · 2020 · 200 citations · Full text

Design, Synthesis, and Characterization of a Series of Cytochrome P₄₅₀3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver^§

Mark D. Erion, K. Raja Reddy, Serge H. Boyer et al. · Journal of the American Chemical Society · 2004 · 157 citations

A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis

Jorge Gomez‐Galeno, Qun Dang, Thanh H. Nguyen et al. · ACS Medicinal Chemistry Letters · 2010 · 91 citations

Chemical Biology, Insulin Signaling, Molecular Pharmacology +18